Molecular Imaging 2017

307 / 1241

Response Assessment: MRI
Restaging:
 Presence/absence of
tumour
 Distance from anal verge
 Tumour length
 Location
 Extramural extension
(mm), location &
distance to CRM
 Presence/absence of
fibrosis
 Presence/absence of
suspicious mesorectal
lymph nodes
 Presence/absence of
suspicious extra- mesorectal
lymph nodes
 yTNM staging
ESGAR Consensus. Beets-Tan et al.
Eur Radiol. 2013; 23: 2522-31